The reduction of anti-cancer drug antagonism by the spatial protection of drugs with PLA-TPGS nanoparticles.
about
Nanotheranostics - application and further development of nanomedicine strategies for advanced theranosticsMaytansine-loaded star-shaped folate-core PLA-TPGS nanoparticles enhancing anticancer activityEnhanced anticancer activity of DM1-loaded star-shaped folate-core PLA-TPGS nanoparticlesReiterated Targeting Peptides on the Nanoparticle Surface Significantly Promote Targeted Vascular Endothelial Growth Factor Gene Delivery to Stem Cells.An Acetamide Derivative as a Camptothecin Sensitizer for Human Non-Small-Cell Lung Cancer Cells through Increased Oxidative Stress and JNK Activation.Triple Negative Breast Cancer: Nanosolutions for a Big Challenge.A novel double-targeted nondrug delivery system for targeting cancer stem cells.Encapsulated paclitaxel nanoparticles exhibit enhanced anti-tumor efficacy in A549 non-small lung cancer cells.A7RC peptide modified paclitaxel liposomes dually target breast cancer.PLA micro- and nano-particles.Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.Radiofrequency ablation of drug-resistant cancer cells using molecularly targeted carboxyl-functionalized biodegradable graphene.Enhanced efficacy of pluronic copolymer micelle encapsulated SCR7 against cancer cell proliferation.Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer.Nanomedicine for the treatment of triple-negative breast cancer.Exploiting cancer's antioxidative weakness through p53 with nanotoxicology.Recent Advances in the Application of Vitamin E TPGS for Drug Delivery.Smart soft-templating synthesis of hollow mesoporous bioactive glass spheres.Recent Advances in the Synthesis and Applications of Ultrasmall Bimetallic Nanoclusters
P2860
Q26860760-B0CC7E05-1819-484E-A599-A4A4484C6EA3Q28654242-0B708CFD-E4D1-456E-9CE4-99642690BA0AQ28654503-C7B38C65-DDAB-4C7A-ABC4-B7B5DFA21767Q37041753-AAC1343D-EED3-4180-9FEF-065005B7A4EDQ37397101-2EAFCD69-593A-43D6-BED4-8B24DC39FFADQ37422972-03E0B9B7-A762-45CC-A0AA-55D262090F72Q37500094-05E28DF9-1F9D-419D-98D0-D6AC4F2F843FQ38822833-20FD9CF5-DCD1-4F4D-826E-A66ECC4BCC69Q38842323-382950CE-2DF8-49C8-9ABF-0B89B00658DBQ38855152-EA58935F-9AD4-43AF-88F9-B6F0CF8DA7FBQ38883912-7B65FA26-9054-4079-9580-2EFF7F97358AQ38897360-BF633C16-8228-4EA5-A48D-DA659588ADC6Q38920218-C8F8D123-1E20-4B04-B2D6-7E81E94C0CF4Q38927972-F22FDABE-4F4C-4F40-8714-6FD4F13C23FFQ41514180-1ABD79F7-BA8E-4DF4-8ABE-0C6B3EF2D677Q45758946-664FDD67-25A9-4D59-B019-D3CB6EC12A61Q46899218-1A88F2DE-639B-409A-A422-89CB19534BADQ47164896-82D44EF4-6BF0-4029-8975-C4DB6F8A310CQ53255936-EE81CF86-8CAB-4B72-B503-668F93220447Q57344562-80F94E95-BE8D-4132-A566-6FE87BF9B8EE
P2860
The reduction of anti-cancer drug antagonism by the spatial protection of drugs with PLA-TPGS nanoparticles.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The reduction of anti-cancer d ...... s with PLA-TPGS nanoparticles.
@en
The reduction of anti-cancer d ...... s with PLA-TPGS nanoparticles.
@nl
type
label
The reduction of anti-cancer d ...... s with PLA-TPGS nanoparticles.
@en
The reduction of anti-cancer d ...... s with PLA-TPGS nanoparticles.
@nl
prefLabel
The reduction of anti-cancer d ...... s with PLA-TPGS nanoparticles.
@en
The reduction of anti-cancer d ...... s with PLA-TPGS nanoparticles.
@nl
P1433
P1476
The reduction of anti-cancer d ...... gs with PLA-TPGS nanoparticles
@en
P2093
Si-Shen Feng
P304
P356
10.1016/J.BIOMATERIALS.2013.12.033
P577
2014-01-15T00:00:00Z